Background In early breast cancer patients with sentinel node metastasis, the effect of
axillary lymph node dissection (ALND) is controversial. The purpose of this study is to …

Sentinel lymph node biopsy (SLNB) has been recommended as the standard performance
for negative sentinel lymph node (SLN) patients without axillary lymph node dissection …

Background Sentinel lymph node biopsy (SLNB) allows for staging of the axillary node
status in early-stage breast cancer (BC) patients and avoiding complete axillary lymph node …

BACKGROUND Surgical recommendation for early‐stage breast carcinoma includes
removal of the primary breast tumor and evaluation of the axillary lymph nodes on the …

Purpose To provide current recommendations on the use of sentinel node biopsy (SNB) for
patients with early-stage breast cancer. Methods PubMed and the Cochrane Library were …

Introduction. There has been recent interest in validity of completion axillary node dissection
after a positive sentinel node. This systematic review aims to ascertain if sentinel lymph …

BACKGROUND: The Z0011-study, a landmark randomised controlled trial (RCT) challenged
the benefits of complete axillary lymph node dissection (ALND) compared with sentinel …

Sentinel lymph node biopsy is now accepted as the initial approach for women with early
stage breast cancer with clinically node-negative disease. We performed a pooled analysis …

OBJECTIVE: The few long-term follow-up data for sentinel lymph node (SLN) negative
breast cancer patients demonstrate a 5-year disease-free survival of 96–98%. It remains to …

Background: Sentinel lymph node (SLN) staging is currently used to avoid complete axillary
dissection in breast cancer patients with negative SLNs. Evidence of a similar efficacy, in …